Andrew S Park
Overview
Explore the profile of Andrew S Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Multani J, Urman R, Park A, Gill K, Vuvu F, Sun K, et al.
Headache
. 2024 Sep;
65(1):68-79.
PMID: 39248147
Objective: To assess changes in real-world use of acute and preventive medications for migraine over a 12-month follow-up period in the United States following initiation of the anti-calcitonin gene-related peptide...
2.
Zhou Z, Urman R, Gill K, Park A, Vuvu F, Patel L, et al.
J Headache Pain
. 2023 Nov;
24(1):153.
PMID: 37946113
Background: New acute and preventive migraine medications are available, but data on current treatment patterns are limited. This study describes migraine treatment patterns among patients initiating novel acute migraine specific...
3.
Chomistek A, Hoffman V, Urman R, Gill K, Ezzy S, Zhou L, et al.
Pain Ther
. 2022 Oct;
11(4):1415-1437.
PMID: 36203078
Introduction: Erenumab, an anti-calcitonin gene-related peptide (CGRP) receptor monoclonal antibody (mAb), was approved by the US Food and Drug Administration in May 2018. Constipation with serious complications was added to...
4.
Scharpf R, Balan A, Ricciuti B, Fiksel J, Cherry C, Wang C, et al.
Cancer Res
. 2022 Sep;
82(21):4058-4078.
PMID: 36074020
Significance: The complex genomic landscape of RAS-mutant tumors is reflective of selection processes in a cancer lineage-specific and context-dependent manner, highlighting differential therapeutic vulnerabilities that can be clinically translated.
5.
Levintow S, Orroth K, Breskin A, Park A, Flores-Arredondo J, Dluzniewski P, et al.
Pharmacoepidemiol Drug Saf
. 2021 Dec;
31(4):383-392.
PMID: 34894377
Purpose: Clinical trials have demonstrated efficacy of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) in reducing risk of cardiovascular disease events, but effectiveness in routine clinical care has not been...
6.
Liew Z, von Ehrenstein O, Ling C, Yuan Y, Meng Q, Cui X, et al.
Toxics
. 2020 Aug;
8(3).
PMID: 32751992
Cerebral palsy (CP) is the most common neuro-motor disability in young children. Disruptions of maternal hormone function during pregnancy have been linked to CP risk. We investigated whether prenatal exposure...
7.
Park A, Ritz B, Yu F, Cockburn M, Heck J
Int J Hyg Environ Health
. 2020 Feb;
226:113486.
PMID: 32087503
Background: A number of epidemiologic studies with a variety of exposure assessment approaches have implicated pesticides as risk factors for childhood cancers. Here we explore the association of pesticide exposure...
8.
Filippini T, Hatch E, Rothman K, Heck J, Park A, Crippa A, et al.
Environ Health Perspect
. 2019 Apr;
127(4):46002.
PMID: 31017485
Background: A causal link between outdoor air pollution and childhood leukemia has been proposed, but some older studies suffer from methodological drawbacks. To the best of our knowledge, no systematic...
9.
von Ehrenstein O, Ling C, Cui X, Cockburn M, Park A, Yu F, et al.
BMJ
. 2019 Mar;
364:l962.
PMID: 30894343
Objective: To examine associations between early developmental exposure to ambient pesticides and autism spectrum disorder. Design: Population based case-control study. Setting: California's main agricultural region, Central Valley, using 1998-2010 birth...
10.
Ling C, Liew Z, von Ehrenstein O, Heck J, Park A, Cui X, et al.
Toxics
. 2018 Jul;
6(3).
PMID: 30037110
Findings from studies of prenatal exposure to pesticides and adverse birth outcomes have been equivocal so far. We examined prenatal exposure to agricultural pesticides in relation to preterm birth and...